Iovance Biotherapeutics
Michael A. has extensive experience in the technology sector, currently serving as a Senior Security Engineer at Iovance Biotherapeutics, Inc. since August 2020, with prior roles including Security Engineer and System Engineer II. At TriNet, from March 2020 to August 2020, Michael held the position of Technology Service Desk Analyst. Michael's previous experience also includes a tenure as a Technical Specialist at Donor Network West from December 2015 to March 2020, and as a Desktop Support Analyst at Thermo Fisher Scientific/Dell in mid-2015. Earlier in 2014, Michael worked as Desktop Support at FP International. Michael is currently pursuing a degree in Cybersecurity at SANS Technology Institute, expected to complete in December 2024, and has an educational background from Las Positas College between 2015 and 2019.
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.